Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

An opsin 5-dopamine pathway mediates light-dependent vascular development in the eye

MT. Nguyen, S. Vemaraju, G. Nayak, Y. Odaka, ED. Buhr, N. Alonzo, U. Tran, M. Batie, BA. Upton, M. Darvas, Z. Kozmik, S. Rao, RS. Hegde, PM. Iuvone, RN. Van Gelder, RA. Lang,

. 2019 ; 21 (4) : 420-429. [pub] 20190401

Language English Country England, Great Britain

Document type Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't

Grant support
R01 EY004864 NEI NIH HHS - United States
R01 EY026921 NEI NIH HHS - United States
R01 EY022917 NEI NIH HHS - United States
T32 GM063483 NIGMS NIH HHS - United States
R01 EY027077 NEI NIH HHS - United States
R01 GM124246 NIGMS NIH HHS - United States
P30 EY001730 NEI NIH HHS - United States
R01 EY027711 NEI NIH HHS - United States
R01 EY014648 NEI NIH HHS - United States

E-resources Online Full text

NLK ProQuest Central from 2000-01-01 to 1 year ago
Health & Medicine (ProQuest) from 2000-01-01 to 1 year ago

During mouse postnatal eye development, the embryonic hyaloid vascular network regresses from the vitreous as an adaption for high-acuity vision. This process occurs with precisely controlled timing. Here, we show that opsin 5 (OPN5; also known as neuropsin)-dependent retinal light responses regulate vascular development in the postnatal eye. In Opn5-null mice, hyaloid vessels regress precociously. We demonstrate that 380-nm light stimulation via OPN5 and VGAT (the vesicular GABA/glycine transporter) in retinal ganglion cells enhances the activity of inner retinal DAT (also known as SLC6A3; a dopamine reuptake transporter) and thus suppresses vitreal dopamine. In turn, dopamine acts directly on hyaloid vascular endothelial cells to suppress the activity of vascular endothelial growth factor receptor 2 (VEGFR2) and promote hyaloid vessel regression. With OPN5 loss of function, the vitreous dopamine level is elevated and results in premature hyaloid regression. These investigations identify violet light as a developmental timing cue that, via an OPN5-dopamine pathway, regulates optic axis clearance in preparation for visual function.

Clinical Engineering Cincinnati Children's Hospital Medical Center Cincinnati OH USA

Department of Ophthalmology Emory University School of Medicine Atlanta GA USA Pharmacology Emory University School of Medicine Atlanta GA USA

Department of Ophthalmology University of Washington Medical School Seattle WA USA

Department of Ophthalmology University of Washington Medical School Seattle WA USA Pathology University of Washington Medical School Seattle WA USA Biological Structure University of Washington Medical School Seattle WA USA

Division of Developmental Biology Cincinnati Children's Hospital Medical Center Cincinnati OH USA

Institute of Molecular Genetics Academy of Sciences of the Czech Republic Prague Czech Republic

Ophthalmic Research Cole Eye Institute Cleveland Clinic Cleveland OH USA

Pathology University of Washington Medical School Seattle WA USA

The Visual Systems Group Abrahamson Pediatric Eye Institute Division of Pediatric Ophthalmology Cincinnati Children's Hospital Medical Center Cincinnati OH USA

The Visual Systems Group Abrahamson Pediatric Eye Institute Division of Pediatric Ophthalmology Cincinnati Children's Hospital Medical Center Cincinnati OH USA Center for Chronobiology Cincinnati Children's Hospital Medical Center Cincinnati OH USA

The Visual Systems Group Abrahamson Pediatric Eye Institute Division of Pediatric Ophthalmology Cincinnati Children's Hospital Medical Center Cincinnati OH USA Center for Chronobiology Cincinnati Children's Hospital Medical Center Cincinnati OH USA Division of Developmental Biology Cincinnati Children's Hospital Medical Center Cincinnati OH USA Department of Ophthalmology University of Cincinnati College of Medicine Cincinnati OH USA

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19027680
003      
CZ-PrNML
005      
20190823105842.0
007      
ta
008      
190813s2019 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1038/s41556-019-0301-x $2 doi
035    __
$a (PubMed)30936473
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Nguyen, Minh-Thanh T $u The Visual Systems Group, Abrahamson Pediatric Eye Institute, Division of Pediatric Ophthalmology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA. Center for Chronobiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
245    13
$a An opsin 5-dopamine pathway mediates light-dependent vascular development in the eye / $c MT. Nguyen, S. Vemaraju, G. Nayak, Y. Odaka, ED. Buhr, N. Alonzo, U. Tran, M. Batie, BA. Upton, M. Darvas, Z. Kozmik, S. Rao, RS. Hegde, PM. Iuvone, RN. Van Gelder, RA. Lang,
520    9_
$a During mouse postnatal eye development, the embryonic hyaloid vascular network regresses from the vitreous as an adaption for high-acuity vision. This process occurs with precisely controlled timing. Here, we show that opsin 5 (OPN5; also known as neuropsin)-dependent retinal light responses regulate vascular development in the postnatal eye. In Opn5-null mice, hyaloid vessels regress precociously. We demonstrate that 380-nm light stimulation via OPN5 and VGAT (the vesicular GABA/glycine transporter) in retinal ganglion cells enhances the activity of inner retinal DAT (also known as SLC6A3; a dopamine reuptake transporter) and thus suppresses vitreal dopamine. In turn, dopamine acts directly on hyaloid vascular endothelial cells to suppress the activity of vascular endothelial growth factor receptor 2 (VEGFR2) and promote hyaloid vessel regression. With OPN5 loss of function, the vitreous dopamine level is elevated and results in premature hyaloid regression. These investigations identify violet light as a developmental timing cue that, via an OPN5-dopamine pathway, regulates optic axis clearance in preparation for visual function.
650    _2
$a zvířata $7 D000818
650    _2
$a dopamin $x metabolismus $7 D004298
650    _2
$a proteiny přenášející dopamin přes plazmatickou membránu $x antagonisté a inhibitory $x chemie $x metabolismus $7 D050483
650    _2
$a cévní endotel $x metabolismus $7 D004730
650    _2
$a oči $x krevní zásobení $x enzymologie $x růst a vývoj $x metabolismus $7 D005123
650    12
$a světlo $7 D008027
650    _2
$a membránové proteiny $x genetika $x metabolismus $7 D008565
650    _2
$a myši $7 D051379
650    _2
$a myši knockoutované $7 D018345
650    _2
$a opsiny $x genetika $x metabolismus $7 D055355
650    _2
$a retinální gangliové buňky $x metabolismus $x účinky záření $7 D012165
650    _2
$a threonin $x metabolismus $7 D013912
650    _2
$a transportéry VIAAT $x fyziologie $7 D050495
650    _2
$a sklivec $x metabolismus $7 D014822
655    _2
$a časopisecké články $7 D016428
655    _2
$a Research Support, N.I.H., Extramural $7 D052061
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Vemaraju, Shruti $u The Visual Systems Group, Abrahamson Pediatric Eye Institute, Division of Pediatric Ophthalmology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA. Center for Chronobiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
700    1_
$a Nayak, Gowri $u The Visual Systems Group, Abrahamson Pediatric Eye Institute, Division of Pediatric Ophthalmology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA. Center for Chronobiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
700    1_
$a Odaka, Yoshinobu $u The Visual Systems Group, Abrahamson Pediatric Eye Institute, Division of Pediatric Ophthalmology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA. Center for Chronobiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
700    1_
$a Buhr, Ethan D $u Department of Ophthalmology, University of Washington Medical School, Seattle, WA, USA.
700    1_
$a Alonzo, Nuria $u The Visual Systems Group, Abrahamson Pediatric Eye Institute, Division of Pediatric Ophthalmology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
700    1_
$a Tran, Uyen $u The Visual Systems Group, Abrahamson Pediatric Eye Institute, Division of Pediatric Ophthalmology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
700    1_
$a Batie, Matthew $u Clinical Engineering, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
700    1_
$a Upton, Brian A $u The Visual Systems Group, Abrahamson Pediatric Eye Institute, Division of Pediatric Ophthalmology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA. Center for Chronobiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
700    1_
$a Darvas, Martin $u Pathology, University of Washington Medical School, Seattle, WA, USA.
700    1_
$a Kozmik, Zbynek $u Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, Prague, Czech Republic.
700    1_
$a Rao, Sujata $u Ophthalmic Research, Cole Eye Institute, Cleveland Clinic, Cleveland, OH, USA.
700    1_
$a Hegde, Rashmi S $u Division of Developmental Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
700    1_
$a Iuvone, P Michael $u Department of Ophthalmology, Emory University School of Medicine, Atlanta, GA, USA. Pharmacology, Emory University School of Medicine, Atlanta, GA, USA.
700    1_
$a Van Gelder, Russell N $u Department of Ophthalmology, University of Washington Medical School, Seattle, WA, USA. Pathology, University of Washington Medical School, Seattle, WA, USA. Biological Structure, University of Washington Medical School, Seattle, WA, USA.
700    1_
$a Lang, Richard A $u The Visual Systems Group, Abrahamson Pediatric Eye Institute, Division of Pediatric Ophthalmology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA. Richard.Lang@cchmc.org. Center for Chronobiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA. Richard.Lang@cchmc.org. Division of Developmental Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA. Richard.Lang@cchmc.org. Department of Ophthalmology, University of Cincinnati, College of Medicine, Cincinnati, OH, USA. Richard.Lang@cchmc.org.
773    0_
$w MED00005249 $t Nature cell biology $x 1476-4679 $g Roč. 21, č. 4 (2019), s. 420-429
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30936473 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20190813 $b ABA008
991    __
$a 20190823110057 $b ABA008
999    __
$a ok $b bmc $g 1432829 $s 1066140
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 21 $c 4 $d 420-429 $e 20190401 $i 1476-4679 $m Nature cell biology $n Nat Cell Biol $x MED00005249
GRA    __
$a R01 EY004864 $p NEI NIH HHS $2 United States
GRA    __
$a R01 EY026921 $p NEI NIH HHS $2 United States
GRA    __
$a R01 EY022917 $p NEI NIH HHS $2 United States
GRA    __
$a T32 GM063483 $p NIGMS NIH HHS $2 United States
GRA    __
$a R01 EY027077 $p NEI NIH HHS $2 United States
GRA    __
$a R01 GM124246 $p NIGMS NIH HHS $2 United States
GRA    __
$a P30 EY001730 $p NEI NIH HHS $2 United States
GRA    __
$a R01 EY027711 $p NEI NIH HHS $2 United States
GRA    __
$a R01 EY014648 $p NEI NIH HHS $2 United States
LZP    __
$a Pubmed-20190813

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...